Topic: Pfizer Inc.
Creates Global Alliance Well Positioned to Deliver Essential Insulin Treatments to Diabetes Patients Worldwide. PFE), the world's leading biopharmaceutical company, today announced that they have entered into a strategic global agreement for the worldwide commercialization of Biocon's biosimilar versions of Insulin and ...
Patients on MACUGEN Maintained and Expanded Vision Gains Over Two Years. NEW YORK, N.Y., (June 5, 2010) /PRNewswire/ - Results from a Phase 3 study demonstrate MACUGEN? (pegaptanib sodium) significantly improved vision in patients with diabetic macular edema (DME), a complication of ...
PFE) said it will turn the focus of its Singapore clinical research unit toward Asia-specific diseases. It also means that Pfizer will investigate diseases that are prevalent around the global, but whose etiology in Asian populations may be different than in the ...
SINGAPORE (Reuters) - Pfizer has said it will conduct more research on Asian populations in coming years to design drugs for diseases prevalent in the region, such as cancers of the liver and head and neck.Its clinical research unit in Singapore - ...
In the United States, initiation of screening for type 2 diabetes between ages 30 and 45, with repeat screenings every three to five years, is cost effective, according to a study published online March 30 in The Lancet.. Richard Kahn, Ph.D., of ...
GlaxoSmithKline shocked the pharmaceutical industry in 2008 when it dropped $720 million to buy Sirtris Pharmaceuticals, a biotechnology company working on drugs based on resveratrol, a chemical in red wine thought to combat the effects of aging.. In the latest salvo, Pfizer ...
Novartis (NVS), which bought $10.4 billion of Alcon (ACL) equity from Nestle (NSRGY. That will make Novartis the owner of approximately 77 percent of the global eye care company. Novartis is also seeking to merge the 23 percent of Alcon it will ...
PFE) has taken on the job of co-promoting a diabetes drug in China for Takeda Pharmaceutical Company. Since 2004, China marketing of Actos was handled by Tianjin Takeda Pharmaceuticals, a JV established by Takeda and a China partner, Tianjin Lisheng Pharmacetical Co. ...
COX) today announced the signature of an agreement with Pfizer Inc to reacquire the full development and commercialization rights to PF-03187207, which has completed two phase 2 studies in patients with primary open angle glaucoma and ocular hypertension. We maintain an excellent ...
Pfizer admitted defeat for its inhaled insulin Exubera, the first medicine of its kind, and said it's halting sales of the drug. Pfizer, he said in the statement, will take "pre-tax charges of $2.8 billion related primarily to the write-off of assets ...
Photo Gallery
-
Pfizer Settlement
FBI Assistant Director of Criminal Investigative Division Kevin Perkins, right, looks on ...AP News - -
Pfizer CEO
Jeffrey Kindler, chairman and CEO of Pfizer, speaks at a news conference ...AP News - -
Pfizer to acquire Wyeth for $68 billion dollars
epa01614571 Jeffery B. Kindler, Chairman and CEO of Pfizer (L) speaks as ...ZUMA Press Inc -
From Around the Web
Video Gallery
-
Pfizer is Recalling Birth Control Pills
Pfizer Inc. is recalling about a million packages of two ...2012-02-01 -
Pfizer Considering Acquisition of Partner Icagen, ...
Drug giant Pfizer Inc (NYSE:PFE) said in a regulatory ...2011-06-27 -
Pfizer Inc. 2010 WBENC Conference
MBEConnect interview with Pfizer Inc on Supplier Diversity at the ...2010-08-17
